Royalty Pharma (RPRX) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.21
- Estimate
- $1.18
- Surprise
- +2.4%
- Revenue (period 2026-09-30)
- $690.1M
- Score today
- 5.1/10
Revenue source: xbrl.
How the report landed
Royalty Pharma (RPRX) beat the $1.18 estimate with adjusted EPS of $1.21 — a modest 2.4% upside surprise.
Coverage in the report window
- Royalty Pharma Reports Third Quarter 2026 Financial Results and Raises Full Year Guidance — fiscal.ai, 2026-11-04
Where TrendMatrix's rating stands now
TrendMatrix currently rates RPRX Hold at 5.1/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +2.4% surprise compares with a +6.4% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (0.2% away)
- Expensive valuation
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $67.56
- Stop
- $64.56
The stock trades at 44.2× trailing but 11.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 83 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.
RPRX at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $39.04B
- P/E (fwd)
- 11.6
- P/E (ttm)
- 44.2
- 52-week range
- $36.03–$67.70
- Off 52-week high
- 0.2%
- RSI (14)
- 83
- Volume vs avg
- 1.17×
- Score today
- 5.1/10